Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

First Adult Seizure

  • Author: Eissa Ibrahim AlEissa, MD, MBBS; Chief Editor: Selim R Benbadis, MD  more...
 
Updated: Jul 06, 2016
 

Background

Many diseases can cause paroxysmal clinical events. The correct diagnosis of the paroxysmal event is necessary to provide correct treatment. If the event is an epileptic seizure, the seizure type and associated clinical, electroencephalographic (EEG) (see an example in the image below), and neuroimaging findings assist in determining the risk of seizure recurrence and the possible need to begin anticonvulsant therapy. Yet, the correct diagnosis is often missed.

Scheepers et al reported 49 patients with an incorrect diagnosis and 26 patients with an uncertain diagnosis among 214 patients with a diagnosis of epilepsy.[1] In addition, about 30% of patients seen at epilepsy centers for refractory seizures turn out to have been misdiagnosed and do not have seizures.[2]

An electroencephalogram (EEG) recording of a tempo An electroencephalogram (EEG) recording of a temporal lobe seizure. The ictal EEG pattern is shown in the rectangular areas.

This article focuses on 2 related questions, as follows:

  • Is the spell an epileptic seizure?
  • If the event is epileptic, is it likely to recur?

Thus, the stepwise approach should be the following:

  • Is it a seizure?
  • Is it epilepsy?
  • What kind of epilepsy?
  • What is the cause?

This article describes the common clinical features of patients with a first seizure, risk factors for seizure recurrence, and a general approach to management.

Definitions

The definitions of the following terms come from the International League Against Epilepsy (ILAE) Guidelines.[3, 4, 5] In 2010, the ILAE proposed revisions to the terminology, classification, and concepts for seizures and epilepsies, but the ILAE indicates these are guiding principles rather than a presentation of new classification per se.[6]

An epileptic seizure is a clinical event presumed to result from an abnormal and excessive neuronal discharge. The clinical symptoms are paroxysmal and may include impaired consciousness and motor, sensory, autonomic, or psychic events perceived by the subject or an observer.

Epilepsy occurs when 2 or more epileptic seizures occur unprovoked by any immediately identifiable cause. The seizures must occur more than 24 hours apart. In epidemiologic studies, an episode of status epilepticus is considered a single seizure. Febrile seizures and neonatal seizures are excluded from this category.

Idiopathic epilepsy describes epilepsy syndromes with specific age-related onset, specific clinical and electrographic characteristics, and a presumed genetic mechanism.

Epileptic seizures are classified as cryptogenic or symptomatic. A cryptogenic seizure is a seizure of unknown etiology, and it is not associated with a previous central nervous system (CNS) insult known to increase the risk of developing epilepsy. A cryptogenic seizure does not conform to the criteria for the idiopathic or symptomatic categories. Previous studies use the term idiopathic to describe a seizure of unknown etiology. However, the ILAE guidelines discourage use of the term idiopathic to describe a seizure of unknown etiology.

Symptomatic seizure is a seizure caused by a previously known or suspected disorder of the CNS. This type of seizure is associated with a previous CNS insult known to increase the risk of developing epilepsy.

An acute symptomatic seizure is one that occurs following a recent acute disorder such as a metabolic insult, toxic insult, CNS infection, stroke, brain trauma, cerebral hemorrhage, medication toxicity, alcohol withdrawal, or drug withdrawal. An example of an acute symptomatic seizure is a seizure that occurs within 1 week of a stroke or head injury. Studies have reported that 25-30% of first seizures are acute symptomatic seizures.[7]

A remote symptomatic seizure is a seizure that occurs longer than 1 week following a disorder that is known to increase the risk of developing epilepsy. The seizure may occur a long time after the disorder. These disorders may produce static or progressive brain lesions. An example of a remote symptomatic seizure is a seizure that first occurs 6 months following a traumatic brain injury or stroke.

Seizures are also classified as provoked or unprovoked. A provoked seizure is an acute symptomatic seizure. An unprovoked seizure is a cryptogenic or a remote symptomatic seizure.

Compared with an epileptic seizure, a nonepileptic event is a clinical event that can mimic, and be mistaken for, an epileptic seizure. Examples of nonepileptic events that mimic seizures include syncope and psychogenic nonepileptic attacks (PNEAs). Syncope is caused by decreased cerebral perfusion that results mostly from a decrease in the cardiac output, which results in loss of consciousness.

For more information on some of the topics discussed here, see the following:

Next

Etiology

Causes of epilepsy include the following:

  • Prenatal, perinatal, or postnatal complications of pregnancy and delivery
  • Febrile seizure, which must be differentiated between a complex febrile seizure and a simple febrile seizure
  • Cerebrovascular disease, such as cerebral infarction, cerebral hemorrhage, and venous thrombosis
  • Head trauma, which is more significant when it occurs with loss of consciousness lasting longer than 30 minutes, posttraumatic amnesia lasting longer than 30 minutes, focal neurologic findings, or neuroimaging findings suggesting a structural brain injury
  • Central nervous system (CNS) infections, such as meningitis or encephalitis
  • Neurodegenerative diseases
  • Autoimmune disease
  • Brain neoplasm
  • Genetic diseases
  • Drug intoxication, drug withdrawal, or alcohol withdrawal
  • Metabolic medical disorders, such as uremia, hypoglycemia, hyponatremia, and hypocalcemia

Risk factors for recurrent seizures include the following:

  • Age younger than 16 years [8] : The risk in this age group is almost double the risk of recurrent seizures in adolescents and adults aged 16-60 years.
  • Remote symptomatic seizure [9, 10, 11] : In the case of seizures after a first stroke, lesion location and stroke subtype are strong predictors of early seizure risk, and early seizures are a predictor of recurrent seizures. [12]
  • Seizures occurring between midnight and 8:59 am [13, 14, 15]
  • Previous provoked seizures [10]
  • Previous febrile seizure [7]
  • Family history of epilepsy [7] : Remote symptomatic seizure may occur in a patient whose sibling is affected with epilepsy.
  • Status epilepticus or multiple seizures within 24 hours as the initial remote symptomatic seizure [10]
  • Partial seizures [9, 11]
  • Todd paralysis in patients with a remote symptomatic seizure [10]
  • History of neurologic deficit from birth, such as cerebral palsy or mental retardation [9]
  • Abnormal examination findings in patients without a remote symptomatic seizure [9, 16]
  • Computed tomography (CT) scan that shows a brain tumor [13]
  • Electroencephalogram (EEG) that shows epileptiform discharges (see below)

Risk of seizure recurrence in patients whose EEG shows epileptiform discharges

In patients with a first seizure and no known etiology, van Donselaar et al’s pooled analyses showed the following 2-year cumulative risks of seizure recurrence[17] : in patients with epileptiform discharges, 83%; in patients with nonepileptiform abnormalities, 41%; and in patients with normal electroencephalogram (EEG), 12%. The investigators obtained a routine EEG in all cases and a second sleep-deprived EEG if the first EEG did not show epileptiform discharges.

Studies in the 1990s also reported the following risks for seizure recurrence:

  • Epileptiform discharges were associated with a 1.5- to 3-fold increase in the risk of seizure recurrence. [8, 11, 18]
  • A generalized spike and wave on EEG increased the risk of recurrent seizure in patients with no known etiology. [10]
  • An abnormal EEG finding and the presence of an underlying etiology (remote symptomatic) are the most consistent predictors of recurrence. [18]
Previous
Next

Epidemiology

It is estimated that 1 in 26 people will develop epilepsy during his or her lifetime.[19]

The incidence of single unprovoked seizures is 23-61 cases per 100,000 persons-years, while the incidence of acute symptomatic seizures is 29-39 cases per 100,000 population per year.[20, 21, 22]

Beghi et al attributed the variability to differences in methodology and definitions.[18] The rates were similar in different geographic areas despite technical differences in the studies.

Racial differences have not been studied, but there appears to be a small to moderate male preponderance of men studies of first adult seizures in most reports.[13, 17, 23, 24] However, in an early study, Annegers et al found a slight overall preponderance of women.[9] Their etiologic categories were neurologic deficit from birth, remote symptomatic, and no known previous etiology. The investigators identified a preponderance of men in the group with neurologic deficit from birth, no sex preponderance in the group with remote symptomatic seizures, and a slight preponderance of women in the group with no known previous etiology.[9] These authors did not determine if these sexual differences were statistically significant.

Among patients who had an initial generalized tonic-clonic seizure, Bora et al found that only 45.5% were men.[14] Patients with partial seizures and structural lesions proven on computed tomography (CT) scan were excluded from this study.

Age does affect the incidence rate of epilepsy, with the highest incidence in the very young and very old groups. The incidence rate in children younger than 1 year is 100-233 per 100,000.[25] The rate decreases in patients aged 20-60 years to 30-40 cases per 100,000, but the rate increases to 100-170 cases per 100,000 in patients older than 65 years.[25]

Previous
Next

Prognosis

A first seizure provoked by an acute brain insult is unlikely to recur (3-10%), whereas a first unprovoked seizure has a recurrence risk of 30-50% over the next 2 years. Even among symptomatic seizures, the recurrence rate differs according to the underlying cause. Seizures associated with reversible metabolic or toxic disturbances are associated with a minor risk of subsequent epilepsy (3% or less based on large case series). Seizures provoked by disorders that cause permanent damage to the brain, such as brain abscess, have a higher risk of recurrence (10% or more).[7]

In a 2009 study, individuals with a first acute symptomatic seizure were found to be significantly more likely to die in the first 30 days after the seizure compared with those with a first unprovoked seizure[26] ; however, the risk of 10-year mortality did not differ. In addition, the risk for subsequent unprovoked seizure was 80% lower in the group with first acute symptomatic seizure compared with those with first unprovoked seizure.[26]

Among medically untreated patients in one study, the cumulative 2-year risk of seizure recurrence was 51%.[8] Hauser et al found that variability in the reported risks of seizure recurrence may have been due to the following[10] :

  • Variations in patient populations: Some studies reflect the risk in referral populations; other studies reflect the risk in a more general patient population.
  • Variations in the specificity and sensitivity of case definitions
  • Misclassification of cases: Hauser et al found that 74% of their patient cohort required exclusion because of a previous unprovoked seizure. [25]
  • Variations in time of ascertainment
  • Biases from retrospective study design
  • Confounding effect of anticonvulsant treatment: Many of the previous studies included patients who received anticonvulsant therapy after their first seizure.

See Etiology for risks factors associated with seizure recurrence.

Previous
Next

Patient Education

Counseling patients about driving after a first seizure revolves around 2 issues: the diagnosis and the chance of recurrence.

Patients who have had a single epileptic seizure are at increased risk of having a second seizure. Therefore, these individuals should be informed that they are at increased risk of injury to themselves or others if another seizure occurs. Risk of injury is especially important if patients are driving, operating dangerous machinery, or performing other activities that could put themselves or others at risk. These same concerns also apply to nonepileptic conditions such as syncope that might recur and put the patient or others at risk of injury. Document this discussion in the patient’s medical record.

The patient should be advised to contact the state agency that regulates driving privileges, as driving regulations vary from state to state. The restrictions sometimes apply to any alteration or loss of consciousness from any etiology. This discussion with the patient should also be documented in the medical record.

Patients with a first epileptic seizure and with risk factors such as remote symptomatic etiology or an electroencephalogram (EEG) with epileptiform discharges are at higher risk for a second seizure. Restrictions of hazardous activity should be more emphatic for these patients.

For patient education information, see the Brain and Nervous System Center, as well as Epilepsy.

Previous
 
 
Contributor Information and Disclosures
Author

Eissa Ibrahim AlEissa, MD, MBBS Consultant Neurologist and Epileptologist, King Salman Hospital, Saudi Arabia

Eissa Ibrahim AlEissa, MD, MBBS is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society

Disclosure: Nothing to disclose.

Coauthor(s)

Selim R Benbadis, MD Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Medical Association, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cyberonics; Eisai; Lundbeck; Sunovion; UCB; Upsher-Smith<br/>Serve(d) as a speaker or a member of a speakers bureau for: Cyberonics; Eisai; Glaxo Smith Kline; Lundbeck; Sunovion; UCB<br/>Received research grant from: Cyberonics; Lundbeck; Sepracor; Sunovion; UCB; Upsher-Smith.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Jose E Cavazos, MD, PhD, FAAN, FANA, FACNS Professor with Tenure, Departments of Neurology, Pharmacology, and Physiology, Assistant Dean for the MD/PhD Program, Program Director of the Clinical Neurophysiology Fellowship, University of Texas School of Medicine at San Antonio; Co-Director, South Texas Comprehensive Epilepsy Center, University Hospital System; Director, San Antonio Veterans Affairs Epilepsy Center of Excellence and Neurodiagnostic Centers, Audie L Murphy Veterans Affairs Medical Center

Jose E Cavazos, MD, PhD, FAAN, FANA, FACNS is a member of the following medical societies: American Academy of Neurology, American Clinical Neurophysiology Society, American Neurological Association, Society for Neuroscience, American Epilepsy Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Brain Sentinel, consultant.<br/>Stakeholder (<5%), Co-founder for: Brain Sentinel.

Chief Editor

Selim R Benbadis, MD Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Medical Association, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cyberonics; Eisai; Lundbeck; Sunovion; UCB; Upsher-Smith<br/>Serve(d) as a speaker or a member of a speakers bureau for: Cyberonics; Eisai; Glaxo Smith Kline; Lundbeck; Sunovion; UCB<br/>Received research grant from: Cyberonics; Lundbeck; Sepracor; Sunovion; UCB; Upsher-Smith.

Additional Contributors

Anthony M Murro, MD Professor, Laboratory Director, Department of Neurology, Medical College of Georgia, Georgia Regents University

Anthony M Murro, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author William J Nowack, MD, to the development and writing of the source article.

References
  1. [Guideline] Anderson P. New AAN/AES guideline on first unprovoked seizure in adults. Medscape Medical News. Available at http://www.medscape.com/viewarticle/843442. Accessed: April 20, 2015.

  2. Annegers JF, Shirts SB, Hauser WA, Kurland LT. Risk of recurrence after an initial unprovoked seizure. Epilepsia. 1986 Jan-Feb. 27(1):43-50. [Medline].

  3. Beghi E, Berg AT, Hauser WA. Treatment of Single Seizures. Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Lippincott-Raven; 1997. 1287-94.

  4. Benbadis SR. Differential diagnosis of epilepsy. Continuum Lifelong Learn Neurol. 2007. 13:48-70.

  5. Benbadis SR. Errors in EEGs and the misdiagnosis of epilepsy: importance, causes, consequences, and proposed remedies. Epilepsy Behav. 2007 Nov. 11(3):257-62. [Medline].

  6. Benbadis SR. Provocative techniques should be used for the diagnosis of psychogenic nonepileptic seizures. Arch Neurol. 2001 Dec. 58(12):2063-5. [Medline].

  7. Benbadis SR. The differential diagnosis of epilepsy: A critical review. Epilepsy Behav. 2009. 15:15-21.

  8. Benbadis SR, Lin K. Errors in EEG interpretation and misdiagnosis of epilepsy. Which EEG patterns are overread?. Eur Neurol. 2008. 59(5):267-71. [Medline].

  9. Benbadis SR, Tatum WO. Overintepretation of EEGs and misdiagnosis of epilepsy. J Clin Neurophysiol. 2003 Feb. 20(1):42-4. [Medline].

  10. Benbadis SR, Wolgamuth BR, Goren H, Brener S, Fouad-Tarazi F. Value of tongue biting in the diagnosis of seizures. Arch Intern Med. 1995 Nov 27. 155(21):2346-9. [Medline].

  11. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010 Apr. 51(4):676-85. [Medline]. [Full Text].

  12. Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology. 1991 Jul. 41(7):965-72. [Medline].

  13. Bora I, Seckin B, Zarifoglu M, Turan F, Sadikoglu S, Ogul E. Risk of recurrence after first unprovoked tonic-clonic seizure in adults. J Neurol. 1995 Feb. 242(3):157-63. [Medline].

  14. Camfield PR, Camfield CS, Dooley JM, Tibbles JA, Fung T, Garner B. Epilepsy after a first unprovoked seizure in childhood. Neurology. 1985 Nov. 35(11):1657-60. [Medline].

  15. Chadwick D, Smith D. Epileptology of the first-seizure presentation. Lancet. 1998 Dec 5. 352(9143):1855; author reply 1856. [Medline].

  16. Chandra B. First seizure in adults: to treat or not to treat. Clin Neurol Neurosurg. 1992. 94 suppl:S61-3. [Medline].

  17. [Guideline] Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia. 1993. 34(4):592-6. [Medline].

  18. [Guideline] Commission on Epidemiology and Prognosis, International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989. 30(4):389-99. [Medline].

  19. [Guideline] Engel J Jr. Report of the ILAE classification core group. Epilepsia. 2006 Sep. 47(9):1558-68. [Medline].

  20. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993 May-Jun. 34(3):453-68. [Medline].

  21. Hauser WA, Beghi E. First seizure definitions and worldwide incidence and mortality. Epilepsia. 2008. 49 Suppl 1:8-12. [Medline].

  22. Hauser WA, Rich SS, Annegers JF, Anderson VE. Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology. 1990 Aug. 40(8):1163-70. [Medline].

  23. Heller AJ, Chesterman P, Elwes RD, et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry. 1995 Jan. 58(1):44-50. [Medline].

  24. Hesdorffer DC, Benn EK, Cascino GD, Hauser WA. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia. 2009 May. 50(5):1102-8. [Medline].

  25. Hesdorffer DC, Logroscino G, Benn EK, Katri N, Cascino G, Hauser WA. Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota. Neurology. 2011 Jan 4. 76(1):23-7. [Medline]. [Full Text].

  26. Hopkins A, Garman A, Clarke C. The first seizure in adult life. Value of clinical features, electroencephalography, and computerised tomographic scanning in prediction of seizure recurrence. Lancet. 1988 Apr 2. 1(8588):721-6. [Medline].

  27. King MA, Newton MR, Jackson GD, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet. 1998 Sep 26. 352(9133):1007-11. [Medline].

  28. Kotsopoulos IA, van Merode T, Kessels FG, de Krom MC, Knottnerus JA. Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia. 2002 Nov. 43(11):1402-9. [Medline].

  29. Krumholz A, Wiebe S, Gronseth GS, Gloss DS, Sanchez AM, Kabir AA, et al. Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015 Apr 21. 84(16):1705-13. [Medline]. [Full Text].

  30. Labovitz DL, Hauser WA, Sacco RL. Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology. 2001 Jul 24. 57(2):200-6. [Medline].

  31. Marson AG, Al-Kharusi AM, Alwaidh M, et al, for the SANAD Study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet. 2007 Mar 24. 369(9566):1000-15. [Medline].

  32. Marson AG, Al-Kharusi AM, Alwaidh M, et al, for the SANAD Study group. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007 Mar 24. 369(9566):1016-26. [Medline].

  33. Martinovic Z, Jovic N. Seizure recurrence after a first generalized tonic-clonic seizure, in children, adolescents and young adults. Seizure. 1997 Dec. 6(6):461-5. [Medline].

  34. Meador KJ, Baker GA, Browning N, et al for the NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009 Apr 16. 360(16):1597-605. [Medline].

  35. Moore-Sledge CM. Evaluation and management of first seizures in adults. Am Fam Physician. 1997 Sep 15. 56(4):1113-20. [Medline].

  36. Musicco M, Beghi E, Bordo B. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. First Seizure Trial Group (FIR.S.T. Group). Neurology. 1993 Mar. 43(3 pt 1):478-83. [Medline].

  37. Musicco M, Beghi E, Solari A, Viani F. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group). Neurology. 1997 Oct. 49(4):991-8. [Medline].

  38. Nowack WJ. Epilepsy: a costly misdiagnosis. Clinical Electroencephalogr. 1997. 28(4):225-228. [Medline].

  39. Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O, Hauser WA. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol. 2005 Oct. 4(10):627-34. [Medline].

  40. Pohlmann-Eden B, Beghi E, Camfield C, Camfield P. The first seizure and its management in adults and children. BMJ. 2006 Feb 11. 332(7537):339-42. [Medline].

  41. van Donselaar CA, Schimsheimer RJ, Geerts AT, Declerck AC. Value of the electroencephalogram in adult patients with untreated idiopathic first seizures. Arch Neurol. 1992 Mar. 49(3):231-7. [Medline].

  42. Zaidi A, Clough P, Cooper P, Scheepers B, Fitzpatrick AP. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol. 2000 Jul. 36(1):181-4. [Medline].

  43. Privitera MD, Brodie MJ, Mattson RH, et al, for the EPMN 105 Study Group. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand. 2003 Mar. 107(3):165-75. [Medline].

  44. Scheepers B, Clough P, Pickles C. The misdiagnosis of epilepsy: findings of a population study. Seizure. 1998 Oct. 7(5):403-6. [Medline].

  45. Schreiner A, Pohlmann-Eden B. Value of the early electroencephalogram after a first unprovoked seizure. Clin Electroencephalogr. 2003 Jul. 34(3):140-4. [Medline].

  46. Sheldon R, Rose S, Ritchie D, et al. Historical criteria that distinguish syncope from seizures. J Am Coll Cardiol. 2002 Jul 3. 40(1):142-8. [Medline].

  47. Simpson CS, Barlow MA, Krahn AD, et al. Recurrent seizure diagnosed by the insertable loop recorder. J Interv Card Electrophysiol. 2000 Oct. 4(3):475-9. [Medline].

  48. Stein MA, Kanner AM. Management of newly diagnosed epilepsy: a practical guide to monotherapy. Drugs. 2009. 69(2):199-222. [Medline].

  49. Tardy B, Lafond P, Convers P, et al. Adult first generalized seizure: etiology, biological tests, EEG, CT scan, in an ED. Am J Emerg Med. 1995 Jan. 13(1):1-5. [Medline].

  50. Tudur Smith C, Marson AG, Chadwick DW, Williamson PR. Multiple treatment comparisons in epilepsy monotherapy trials. Trials. 2007 Nov 5. 8:34. [Medline]. [Full Text].

 
Previous
Next
 
An electroencephalogram (EEG) recording of a temporal lobe seizure. The ictal EEG pattern is shown in the rectangular areas.
An electroencephalogram (EEG) recording from a patient with primary generalized epilepsy. A burst of bilateral spike and wave discharge is shown in the rectangular area.
An electroencephalogram (EEG) recording of a seizure from a subdural array in a patient evaluated for epilepsy surgery. The subdural electrodes record from the left anterior temporal (LAT), left middle temporal (LMT), and left posterior temporal (LPT) regions. The EEG seizure pattern is seen best in bipolar EEG channels LAT 3-4 and LMT 3-4 (rectangular areas).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.